Finance

Lists
Why is RGT down 6,67%?
Dive Deeper
RGT:ASX
Argent BioPharma Ltd
0,028 A$
-6,67%
(-0,0020) 1D
5 қаз., 11:07:45 GMT+11  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for RGT...
Open
0,03 A$
High
0,03 A$
Low
0,03 A$
Mkt. cap
3,27 млн
Avg. vol.
136,40 м.
Volume
168,68 м.
52-wk high
0,11 A$
52-wk low
0,03 A$
EPS
-0,09 A$
Shares outstanding
117,86 млн
Open
0,03 A$
High
0,03 A$
Low
0,03 A$
Mkt. cap
3,27 млн
Avg. vol.
136,40 м.
Volume
168,68 м.
52-wk high
0,11 A$
52-wk low
0,03 A$
EPS
-0,09 A$
Shares outstanding
117,86 млн
News stories
From web sources and news partners
About Argent BioPharma Ltd
CEORoby Zomer
Employees-
Founded2005
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
85,75 мың
85,75 мың
-5,16 мың
-5,16 мың
Cost of goods sold
103,51 м.
103,51 м.
-3,11 мың
-3,11 мың
Cost of revenue
103,51 м.
103,51 м.
-3,11 мың
-3,11 мың
Research and development expenses
201,15 м.
201,15 м.
43,94 мың
43,94 мың
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,26 млн
1,26 млн
2,17 млн
2,17 млн
Operating expense
1,47 млн
1,47 млн
2,22 млн
2,22 млн
Total operating expenses
1,58 млн
1,58 млн
2,22 млн
2,22 млн
Operating income
-1,49 млн
-1,49 млн
-2,22 млн
-2,22 млн
Other non operating income
66,88 мың
66,88 мың
-367,79 м.
-367,79 м.
EBT including unusual items
-1,47 млн
-1,47 млн
-2,39 млн
-2,39 млн
EBT excluding unusual items
-1,44 млн
-1,44 млн
-2,38 млн
-2,38 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
13,05 мың
13,05 мың
4,24 мың
4,24 мың
Net income
-1,47 млн
-1,47 млн
-2,39 млн
-2,39 млн
Net profit margin
-1 711,52%
-1 711,52%
46 304,27%
46 304,27%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-16,75 мың
-16,75 мың
-102,00
-102,00
Net interest expenses
-16,75 мың
-16,75 мың
-102,00
-102,00
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,47 млн
-1,47 млн
-2,22 млн
-2,22 млн
Gain or loss from assets sale
-
-
40,38 мың
40,38 мың
AI content may include mistakes. Learn more
Google қолданбалары